Development of a prediction system for anti-tuberculosis drug-induced liver injury in Japanese patie...
Development of a prediction system for anti-tuberculosis drug-induced liver injury in Japanese patients
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Drug-induced liver injury (DILI) is a common adverse drug reaction in patients receiving antituberculosis (anti-TB) treatment. Among the anti-TB agents, isoniazid (INH) is the primary drug that causes hepatotoxicity in TB patients with DILI. Previous reports in several populations have consistently demonstrated an association between polymorphisms...
Alternative Titles
Full title
Development of a prediction system for anti-tuberculosis drug-induced liver injury in Japanese patients
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4917605
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4917605
Other Identifiers
ISSN
2054-345X
E-ISSN
2054-345X
DOI
10.1038/hgv.2016.14
